NO974322D0 - DNA som koder for human papillomvirus type 18 - Google Patents

DNA som koder for human papillomvirus type 18

Info

Publication number: NO974322D0
Authority: NO; Norway
Prior art keywords: dna encoding; encoding human; human papillomavirus; papillomavirus type; type
Prior art date: 1995-03-22

Application number

NO974322A

Other languages

English (en)

Other versions

NO322254B1 (no

NO974322L (no

Inventor

Kathryn J Hofmann

Kathrin U Jansen

Michael P Neeper

Joseph G Joyce

Hugh A George

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-22

Filing date

1997-09-19

Publication date

1997-09-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO974322(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-03-22 Priority claimed from US08/409,122 external-priority patent/US5820870A/en

1995-03-22 Priority claimed from US08/408,669 external-priority patent/US5840306A/en

1997-09-19 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

1997-09-19 Publication of NO974322D0 publication Critical patent/NO974322D0/no

1997-11-24 Publication of NO974322L publication Critical patent/NO974322L/no

2006-09-04 Publication of NO322254B1 publication Critical patent/NO322254B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/905—Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
- C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Virology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Mycology (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Oncology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Saccharide Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO19974322A 1995-03-22 1997-09-19 Virusliknende partikler samt fremgangsmate for fremstilling av disse, rekombinant papillomavirusantigen, vaksine,isolert og renset HPV18L1-DNA-molekeyl og anvendelse av dette. NO322254B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/409,122 US5820870A (en)	1995-03-22	1995-03-22	Recombinant human papillomavirus type 18 vaccine
US08/408,669 US5840306A (en)	1995-03-22	1995-03-22	DNA encoding human papillomavirus type 18
PCT/US1996/003649 WO1996029413A2 (en)	1995-03-22	1996-03-18	Dna encoding human papilloma virus type 18

Publications (3)

Publication Number	Publication Date
NO974322D0 true NO974322D0 (no)	1997-09-19
NO974322L NO974322L (no)	1997-11-24
NO322254B1 NO322254B1 (no)	2006-09-04

Family

ID=27020342

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19974322A NO322254B1 (no)	1995-03-22	1997-09-19	Virusliknende partikler samt fremgangsmate for fremstilling av disse, rekombinant papillomavirusantigen, vaksine,isolert og renset HPV18L1-DNA-molekeyl og anvendelse av dette.

Country Status (22)

Country	Link
EP (2)	EP0817851B9 (no)
JP (1)	JPH11502704A (no)
KR (1)	KR100430698B1 (no)
CN (1)	CN1100876C (no)
AT (1)	ATE259879T1 (no)
AU (1)	AU714533B2 (no)
CA (1)	CA2215834C (no)
CZ (1)	CZ291242B6 (no)
DE (4)	DE122007000031I1 (no)
DK (1)	DK0817851T5 (no)
EA (1)	EA001092B1 (no)
ES (1)	ES2213772T3 (no)
FR (1)	FR07C0023I2 (no)
HU (1)	HU223761B1 (no)
IL (1)	IL117459A (no)
NL (3)	NL300272I1 (no)
NO (1)	NO322254B1 (no)
NZ (1)	NZ305188A (no)
PL (1)	PL184022B1 (no)
PT (1)	PT817851E (no)
SK (1)	SK284281B6 (no)
WO (1)	WO1996029413A2 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9621091D0 (en)	1996-10-09	1996-11-27	Fondation Pour Le Perfectionem	Attenuated microorganisms strains and their uses
SK138199A3 (en) *	1997-04-08	2000-06-12	Merck & Co Inc	Human papillomavirus antigen formulation and method for stabilizing a population of virus-like purified particles, derived from protein l1 or protein l1 and l2 of human papillomavirus
ZA982950B (en)	1997-04-08	1998-10-19	Merck & Co Inc	Stabilized human papillomavirus formulations
PL347472A1 (en) *	1998-08-14	2002-04-08	Merck & Co Inc	Process for purifying human papillomavirus virus-like particles
AUPP765398A0 (en)	1998-12-11	1999-01-14	University Of Queensland, The	Treatment of papillomavirus infections
DE60040727D1 (de)	1999-02-05	2008-12-18	Merck & Co Inc	Menschliche papillomavirus impfstoff-formulierungen
FR2795074A1 (fr) *	1999-05-21	2000-12-22	Inst Nat Sante Rech Med	Polypeptides transporteurs d'acides amines, et en particulier du glutamate, et procedes de criblage de composes inhibiteurs ou activateurs de l'activite de transport
MXPA05010285A (es) *	2003-03-24	2005-11-17	Merck & Co Inc	Expresion optimizada de hpv 31 l1 en levadura.
MY140664A (en) *	2003-09-29	2010-01-15	Merck Sharp & Dohme	Optimized expression of hpv 45 l1 in yeast
TWI457133B (zh)	2005-12-13	2014-10-21	Glaxosmithkline Biolog Sa	新穎組合物
BRPI0811016B1 (pt)	2007-04-29	2021-09-21	Xiamen Innovax Biotech Co., Ltd.	Proteína li truncada do papiloma vírus humano tipo 16
DK2147926T3 (en) *	2007-04-29	2016-11-28	Beijing Wantai Biological Pharmacy Entpr Co Ltd	Truncated human papillomavirus type 18 L1 protein
CN101440373B (zh) *	2007-11-23	2012-09-05	上海泽润生物科技有限公司	一种截短型的18型人乳头状瘤病毒主要衣壳蛋白l1基因
BRPI1014718A2 (pt) *	2009-06-25	2016-04-12	Glaxonsmithkline Biolog S A	polipeptídeo do papiloma vírus humano, capsômero, partícula tipo vírus, composição imunogência, molécula de ácido nucléico, e, métodos para produzir o polipeptídeo, e, para preparar uma composição imunogênica
US8871466B2 (en) *	2011-06-15	2014-10-28	Chung-Ang University Industry-Academic Cooperation Foundation	Method for enhancing the production yield of human papillomavirus L1 protein
JP2015514696A (ja)	2012-03-18	2015-05-21	グラクソスミスクラインバイオロジカルズソシエテアノニム	ヒト・パピローマウイルスに対するワクチン接種方法
CN108276491B (zh) *	2018-02-05	2021-01-12	南京薇熙生物医药科技有限公司	一种可特异性识别hpv18 l1蛋白的单克隆抗体及其应用
KR102767403B1 (ko)	2019-07-19	2025-02-14	사이노셀테크 엘티디.	키메라 유두종바이러스 l1 단백질
ES3017868T3 (en)	2022-07-07	2025-05-13	Permobil Ab	Powered midwheel drive wheelchair with standing capability

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3625257A1 (de) *	1986-07-23	1988-02-04	Behringwerke Ag	Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika
DE4015044A1 (de) *	1990-05-10	1991-11-14	Behringwerke Ag	Seroreaktive epitope auf proteinen des menschlichen papillomavirus (hpv) 18
EP1471147A3 (en) *	1991-07-19	2007-03-21	The University Of Queensland	Method of making a recombinant molecule for the expression of HPV-16 L1 protein
DE122007000100I1 (de) *	1992-06-25	2008-03-27		Papillomavirus vakzine
US5437951A (en) *	1992-09-03	1995-08-01	The United States Of America As Represented By The Department Of Health And Human Services	Self-assembling recombinant papillomavirus capsid proteins
EP1588713B1 (en) *	1993-03-09	2010-12-22	The University Of Rochester	Production of human papillomavirus HBV-11 capsid protein L1 and virus-like particles

1996
- 1996-03-13 IL IL11745996A patent/IL117459A/xx active Protection Beyond IP Right Term
- 1996-03-18 EP EP96909743A patent/EP0817851B9/en not_active Expired - Lifetime
- 1996-03-18 EP EP04075256A patent/EP1422294A1/en not_active Withdrawn
- 1996-03-18 NZ NZ305188A patent/NZ305188A/xx not_active IP Right Cessation
- 1996-03-18 CZ CZ19972936A patent/CZ291242B6/cs not_active IP Right Cessation
- 1996-03-18 DE DE200712000031 patent/DE122007000031I1/de active Pending
- 1996-03-18 SK SK1278-97A patent/SK284281B6/sk not_active IP Right Cessation
- 1996-03-18 PT PT96909743T patent/PT817851E/pt unknown
- 1996-03-18 EA EA199700256A patent/EA001092B1/ru not_active IP Right Cessation
- 1996-03-18 DE DE69631586T patent/DE69631586T9/de active Active
- 1996-03-18 DE DE1996631586 patent/DE122007000025I1/de active Pending
- 1996-03-18 CA CA002215834A patent/CA2215834C/en not_active Expired - Lifetime
- 1996-03-18 ES ES96909743T patent/ES2213772T3/es not_active Expired - Lifetime
- 1996-03-18 HU HU9801334A patent/HU223761B1/hu active IP Right Grant
- 1996-03-18 DK DK96909743T patent/DK0817851T5/da active
- 1996-03-18 CN CN96194121A patent/CN1100876C/zh not_active Expired - Lifetime
- 1996-03-18 AU AU53141/96A patent/AU714533B2/en not_active Expired
- 1996-03-18 PL PL96322333A patent/PL184022B1/pl unknown
- 1996-03-18 JP JP8528535A patent/JPH11502704A/ja active Pending
- 1996-03-18 DE DE200712000030 patent/DE122007000030I1/de active Pending
- 1996-03-18 KR KR1019970706580A patent/KR100430698B1/ko not_active Expired - Lifetime
- 1996-03-18 AT AT96909743T patent/ATE259879T1/de active
- 1996-03-18 WO PCT/US1996/003649 patent/WO1996029413A2/en not_active Ceased
1997
- 1997-09-19 NO NO19974322A patent/NO322254B1/no not_active IP Right Cessation
2007
- 2007-03-14 NL NL300272C patent/NL300272I1/nl unknown
- 2007-03-14 NL NL300271C patent/NL300271I1/nl unknown
- 2007-03-14 NL NL300273C patent/NL300273I1/nl unknown
- 2007-03-20 FR FR07C0023C patent/FR07C0023I2/fr active Active

Also Published As

Publication number	Publication date
EP0817851B9 (en)	2004-08-18
AU714533B2 (en)	2000-01-06
ES2213772T3 (es)	2004-09-01
FR07C0023I2 (fr)	2012-08-03
HU223761B1 (hu)	2005-01-28
DE122007000025I1 (de)	2007-07-12
DE122007000030I1 (de)	2007-07-19
NL300271I1 (nl)	2007-05-01
DE69631586T2 (de)	2005-01-27
EP0817851A2 (en)	1998-01-14
DK0817851T3 (da)	2004-08-16
DE122007000031I1 (de)	2007-07-19
SK284281B6 (sk)	2004-12-01
IL117459A (en)	2005-11-20
CA2215834C (en)	2007-06-12
EA199700256A1 (ru)	1999-06-24
ATE259879T1 (de)	2004-03-15
IL117459A0 (en)	1996-07-23
CZ291242B6 (cs)	2003-01-15
WO1996029413A3 (en)	1996-11-28
JPH11502704A (ja)	1999-03-09
EA001092B1 (ru)	2000-10-30
DE69631586D1 (de)	2004-03-25
CN1100876C (zh)	2003-02-05
NZ305188A (en)	1999-11-29
PT817851E (pt)	2004-06-30
NO322254B1 (no)	2006-09-04
WO1996029413A2 (en)	1996-09-26
KR100430698B1 (ko)	2004-07-15
EP1422294A1 (en)	2004-05-26
HUP9801334A3 (en)	1999-04-28
CN1185176A (zh)	1998-06-17
FR07C0023I1 (no)	2007-04-27
PL322333A1 (en)	1998-01-19
DK0817851T5 (da)	2004-10-25
CZ293697A3 (cs)	1998-02-18
MX9707208A (es)	1997-11-29
CA2215834A1 (en)	1996-09-26
NL300273I1 (nl)	2007-05-01
SK127897A3 (en)	1998-07-08
NL300272I1 (nl)	2007-05-01
EP0817851B1 (en)	2004-02-18
AU5314196A (en)	1996-10-08
PL184022B1 (pl)	2002-08-30
HUP9801334A2 (hu)	1998-08-28
DE69631586T9 (de)	2005-06-16
NO974322L (no)	1997-11-24

Publication	Publication Date	Title
NL300272I1 (nl)	2007-05-01	DNA dat humaan papillomavirus type 18 codeert.
TR199600084A2 (tr)	1996-08-21	Sismanlamaya karsi proteinler.
ATE141946T1 (de)	1996-09-15	Hiv-2-virusvarianten
NO971875D0 (no)	1997-04-23	Cathepsin 02 protease
NO965084D0 (no)	1996-11-28	N-[3(3-cyanopyrazol[1,5-aÅpyrimidin-7-yl)fenylÅ-N-etyl-acetamid
PT754407E (pt)	2002-06-28	Formulacoes liquidas de 1,2-benzisotiazolin-3-ona
EP0845457A4 (en)	1998-10-07	2,2-dideutero-5-aminolevulinic acid
FI972030L (fi)	1997-05-13	Puhdistettuja papillomavirusproteiineja
NO971347D0 (no)	1997-03-21	DNA som koder for humant papillomvirus type 6A
FI970448A7 (fi)	1997-04-03	N-substituoituja 3-atsobisyklo(3.2.0)heptaanijohdannaisia,jotka ovat k äyttökelpoisia neuroleptisina aineina
DK0990703T3 (da)	2008-09-29	Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
TR199600932T1 (tr)	1997-03-21	Yeni peptidlerin bagisiklik düzenleyici (immünomodülatör)etkileri.
SE9602822D0 (sv)	1996-07-19	New receptor
TR199501328A2 (tr)	1996-06-21	Alzheimer peptidi.
ES2073495T3 (es)	1995-08-16	Benzotiazepinas.
ES2191785T3 (es)	2003-09-16	Proteina de accion antitumoral.
SE9604439D0 (sv)	1996-12-02	New receptor
IT1295973B1 (it)	1999-05-28	Procedimento per l'illuminazione di oggetti.
TR199801087T2 (xx)	1998-09-21	4,10 �- diasetoksi-2alfa-Benzoiloksi- 5 �, 20 epoksi-1- hidroksi-9- okso-19- norsiklopropa(G) taks-11- en- 13alfa-il
KR950024792U (ko)	1995-09-15	차량용 엘. 피. 지 캡(l. p. g cap)
MX9707457A (es)	1998-01-31	Acido desoxirribonucleico sintetico hibrido l1 de hpv6/11 que codifica proteina l1 de virus de papiloma humano tipo 11.
ITRM940330A0 (it)	1994-05-26	"procedimento migliorato per la preparazione della 14b-idrossi-etianaldeide".
TR199600085A2 (tr)	1996-08-21	Sismanlamaya karsi proteinler.
BR7501914U (pt)	1998-04-14	Pizza's ref. 20/40
ITBO970106A0 (it)	1997-02-27	Girello per bambini.

Legal Events

Date	Code	Title	Description
2016-03-29	MK1K	Patent expired